chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I experienced extreme high glucose, started generally within two hours of the vaccine. I can say this happened 9pm at night. There are days that my glucose were in the 500's. I thought this was crazy and I was dealing with my glucose levels and I was having problems and contacted my endocrinologist. Then numbness started at 07:00am on 01-19-2021, my fingers went numb, my legs were hurting and had a high glucose level of 347 at night. I kept recording high glucose levels on my cell phone and I was still at the 300 range. The neuropathy was laying dormant and for some unknown reason that second vaccine blew up my whole system where I could feel the neuropathy. Being that it was possible that my neuropathy was there but it made that reaction happened. I had several neuropathy tests done and saw a podiatrist. I took Gabapentin and also Oxcarbazepine 150mg medication which I take at bed night. I also was prescribed lidocaine patches 5% and Lidocaine 2.5% and prilocaine cream for my burning sensation in my feet. I still continue with the neuropathy and numbness today. My insulin dosage went up by 20%. I stayed like this for close to three months and only went down by 10%.
Hot spot like hives at injection sight; Bright red spot like hives at injection sight; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE URTICARIA (Hot spot like hives at injection sight) and VACCINATION SITE ERYTHEMA (Bright red spot like hives at injection sight) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE URTICARIA (Hot spot like hives at injection sight) and VACCINATION SITE ERYTHEMA (Bright red spot like hives at injection sight). At the time of the report, INJECTION SITE URTICARIA (Hot spot like hives at injection sight) and VACCINATION SITE ERYTHEMA (Bright red spot like hives at injection sight) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided.  No treatment medication were provided.
patient got hot flash and tongue felt like she ate a hot pepper, reaction stopped than happened again in around a minute. observing patient for 30 minutes following vaccine
the same night after taking the vaccine throat became sore, a couple days later lymph nodes in throat became swollen,  it became hard for her to swallow,
Feeling very ill; Extreme diarrhea; Weak; Congestion; Really sick; Fever of 101; Headache; Muscle pain, Terrible aches and pain; A spontaneous report, was received from a consumer (patient's daughter), concerning her mother who was an 88-year-old white female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced feeling very ill (malaise), extreme diarrhea (diarrhea),  weak (asthenia), congestion (nasal congestion), really sick (illness), fever of 101 (pyrexia), headaches, and muscle pain/terrible aches and pain (myalgia).  The patient's medical history included COVID-19 infection and heart valve replacement. Concomitant medication reported included unspecified blood thinners.  On 05 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly for prophylaxis of COVID-19 infection.   On the same day, 05 Jan 2021 at home, the patient experienced very ill, extreme diarrhea, terrible aches and pain, running a fever of 101-degree Fahrenheit (F) and really sick. It took seven hours and 20 minutes sitting in the car for the shot. The patient fever was now down to 100 F. The patient's diarrhea had stopped and just weak with headaches, congestion and muscle pains. The consumer stated that the symptoms were similar to COVID-19 symptoms, which the patient had before, but not as bad. It was noted that the patient was sick for two weeks and took a couple more weeks to recover. The patient was not hospitalized and only a few weeks ago, she felt strong enough to stop using her walker and cane as her muscles were very week from COVID. The patient was up all night long sick. The treatment for the events included gatorade and acetaminophen. The patient finally got to eat a little bit slowly.  Action taken with second dose of mRNA-1273 in response to the events was not provided.  The outcome for the events, feeling very ill, extreme diarrhea, terrible aches and pain, weak, congestion, really sick, fever of 101, headaches, and muscle pains was considered as resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  The patient's advanced age and previous COVID infection are contributing factors for general illness and weakness.
8/17/21 history of htn, DM2 presenting to the ED with complaints of fatigue with exertion
Initially experienced moderate numbness across forehead within a couple of hours of receiving injection.  Over next several hours numbness intensity increased and spread to entire left side of face, extending to the  past the left ear.     When I looked in the mirror saw pronounced droop at left corner of my mouth.
Case number of PHEH2013US015144 is an initial spontaneous report received from a health care professional on 16 Jul 2013: This report refers to a patient of unknown age and gender. This patient was only given MenCYW-135 component of MENVEO (batch number: M11073), without being reconstituted with MenA, on an unspecified date. No adverse event was reported following this administration error.
10/14 started getting headaches joint and muscle aches , 10/16 headaches worse took Tylenol for migraine. 10/17 330p extreme pain face to ear to head tylnol helped 10/18. Went to ed at hospital at 11am cat scan showed rt side brain bleed. ended up in hospital ICU ' treated and released 4days later. my PCP wanted me to report the reaction.
I had surgery in pinkie, ring and middle finger (frozen after accident).  The hand tingles now and any pressure on shoulder, wrist area (leaning to write) or elbow makes those 3 fingers tingle.  The muscle at the back of the armpit is tight.
Patient admitted to the hospital 11/8 with acute Heart failure, new anemia, dyspnea, and chest pressure.
This case was reported by a nurse via call center representative and described the occurrence of injected limb mobility decreased in a 19-year-old female patient who received BEXSERO for prophylaxis. On 6th December 2018, the patient received the 2nd dose of BEXSERO (intramuscular). On 6th December 2018, unknown after receiving BEXSERO, the patient experienced vaccine administered at inappropriate site. On 7th December 2018, the patient experienced injected limb mobility decreased, injection site pain, muscle pain and fever. On 7th December 2018, the outcome of the injected limb mobility decreased was recovered/resolved. On an unknown date, the outcome of the injection site pain, muscle pain, fever and vaccine administered at inappropriate site were unknown. It was unknown if the reporter considered the injected limb mobility decreased, injection site pain, muscle pain and fever to be related to BEXSERO. Additional details were provided as follows: This case was reported by the patient's mother. The patient experienced arm pain, muscle pain and fever. The patient woke up at 4 am and could not move her arm due to the pain but that she was able to move her arm at the time of reporting. The reporter was concerned that, the injection site appears to be too high on the arm and might had gone into the joint, which led to vaccine administered at inappropriate site.
This spontaneous report as received from a nurse refers to a 12 year old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 21-SEP-2017, the patient was vaccinated with improperly stored GARDASIL 9 (dosing details were not reported) (lot # N019923, expiry date: 28-APR-2019) for prophylaxis. No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as from 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA000054: US-009507513-1709USA007012: US-009507513-1709USA007011: US-009507513-1709USA007014.
Minor Bells palsy on left (injection side); asymmetrical smile and gait, and left eyelid drooping, and a marked difference in hand grip strength.
We hosted a dinner for the family, and my granddaughter informed us she was around a friend who tested positive. I started experiencing mild body aches, fever, and runny nose through the weekend and decided to take an at-home COVID-19 test on  11/30/2022. The test came back positive and called my doctor since I originally had an in-visit office appointment that next day; I told my doctor about my symptoms, and he informed me since my symptoms were mild to just rest, stay hydrated and take ibuprofen if needed. After some days, my symptoms went away, and I recovered.
Initial unsolicited report received from pharmacist via other company (Merck) on 23 August 2016. This case involves a patient (age and gender not reported) who was vaccinated with dose of FLUZONE (batch number, expiry date, dose, dose in series, route and site of administration not reported) on an unspecified date. The patient's medical history and concomitant medications were not reported. On an unspecified date, following the vaccination, the patient experienced anaphylactic reaction a decade ago. The patient's lab tests and corrective treatment were not reported. The outcome of the event was unknown. Upon medical review, the case was considered as serious due to important medical event: anaphylactic reaction. List of documents held by sender: none. Sender's Comments: Anaphylactic reaction is unlisted with INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE. This case is very poorly documented to assess the role of the vaccine. However, investigation results ruling out a concurrent infection and other etiologies would be helpful to further assess this case.
A non-serious spontaneous report of administration of expired product was received from a consumer concerning a 13-year-old female. There was no adverse event associated with this medication error 20 days after the error occurred; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.
LEFT HAND NUMBNESS; TINGLING OF THE TIPS OF THE LEFT HAND FINGERS; SORE RIGHT ARM; This spontaneous report received from a patient concerned a 50 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included acid reflux for more than 10 years, alcohol user 4 times a week, and non smoker, and other pre-existing medical conditions included the patient had no known drug allergies and no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A expiry: 21/JUN/2021) dose was not reported, administered on 09-APR-2021 16:15 for prophylactic vaccination. Concomitant medications included omeprazole for acid reflux.  On 09-APR-2021, the subject experienced sore right arm. On 13-APR-2021, the subject experienced left hand numbness. On 13-APR-2021, the subject experienced tingling of the tips of the left hand fingers. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from left hand numbness on 13-APR-2021, was recovering from sore right arm, and had not recovered from tingling of the tips of the left hand fingers. This report was non-serious.
Death 2/6/08.  3/18/08 Reviewed autopsy report which states COD as SIDS. Autopsy states patient found face down atop baby blankets on floor.  Autopsy findings insufficient to explain death.  PMH: viral URI 1/2008.  No other recent illlness or sick contacts.  Birth history unremarkable.
For 24 hours I experienced body aches, chills, and fatigue, heart palpitations, and HEAD RUSHES with TINNITUS.  This went away, but then since receiving my COVID Booster with Pfizer on October 31st at local pharmacy, I have been having worsening, frequent, almost cyclic episodes of HEAD RUSHES with TINNITUS and VERTIGO ever since.
approx 1 hr following vax pt began crying unconsolably;cry is persistent, high pitched;has been using acetominophen q 4hrs;advised to see PMD, who prescribed Motrin, crying & fussiness resolved 22JUN95
Patient states: Chills began 16 hours post vaccination, lasting for a couple hours. Then a sensation of pins and needles all over her body, one area at a time lasting for at least two hours. Pt took tylenol.
This spontaneous report as received from a physician refers to a 13 year old patient of unknown gender. The patient's concurrent conditions, concomitant medications, pertinent medical history and drug reactions or allergies were not provided. On 22-AUG-2017, the patient was vaccinated with an improperly stored dose of GARDASIL 9, lot # M040412 with expiration date on 30-JUN-2019 (dose and route of administration were not reported). Since 19-MAY-2017, the administered dose of GARDASIL 9 underwent multiple temperature excursions between 33 degrees Fahrenheit and 50 degrees Fahrenheit, which lasted for 16, 40, 46 or 70 hours. A digital data logger was not involved in recording the excursion. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA012764.
developed sx of covid 4/7- tested positive on home test 4/8- is up to date with Moderna vax, booster dose info above
Within 15 minutes I had an allergic reaction consisting of my lips, nose and tongue began to tingle and went numb, my tongue Bagan to swell and my blood pressure dropped and I was having trouble staying awake and speaking clearly
Left shoulder pain in injection site w/in hours of administration, continued pain and lost of ROM over next two weeks.
4-inch circle at injection site that was inflamed; 4-inch circle at injection site that was hot to the touch; feverish on and off; pain when raising arm/ at bottom of the deltoid; tired/ still tired; arm was sore at injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th May 2022, the patient received the 1st dose of Shingrix (intramuscular). On 18th May 2022, less than a day after receiving Shingrix, the patient experienced injection site pain, tiredness and pain in arm. On 20th May 2022, the patient experienced injection site inflammation, injection site warmth and fever. On an unknown date, the outcome of the injection site pain, tiredness and pain in arm were not recovered/not resolved and the outcome of the injection site inflammation, injection site warmth and fever were recovered/resolved.   It was unknown if the reporter considered the injection site pain, injection site inflammation, injection site warmth, tiredness, fever and pain in arm to be related to Shingrix.     Additional Information: GSK Receipt Date: 25-Jul-2022. Reporter's Comments: The case was self reported by the patient. The patient received Shingrix on left arm. The reporter reported that the HCP (health care professional) that gave the Shingrix vaccine gave the shot very low on the deltoid muscle but still within parameters. The reporter reported that right after receiving the Shingrix vaccine her arm was sore at the injection site but nothing unusual. Two days after receiving the Shingrix vaccine she developed a 4 inch circle at the injection site that was inflamed and hot to the touch the patient was also tired and feverish on and off, also reported pain when raising her left arm. On 20th May 2022, 2 days after receiving Shingrix, the patient experienced injection site inflammation, injection site warmth and fever. The symptoms resolved at this point except the patient was still tired and pain at the injection site when raising her left arm. The reporter reported that at 9 weeks out from her Shingrix vaccine, that when she raises her left arm, she still feels pain at the bottom of the deltoid where the shot was given. The reporter had not contacted her HCP about this.  The reporter would like to talk to Safety at GSK before contacting the HCP and deciding to get the second Shingrix vaccine that was due between now and 18th November 2022.  The reporter inquired had anyone else experienced this. The reporter did not consent to follow-up.  The reporter did not give permission to contact HCP, reporter originally gave her street address then retracted it. The reporter would like to be contacted by her cell phone either by text message or leave a message.
Patient came to the pharmacy expecting to received the PREVNAR 13 vaccine. Miscommunication occurred and the patient received the FLUAD vaccine on 12/4/17 at approximately 11:45am. By 12:15pm the patient arrived home and noticed his patient receipt was for the FLUAD vaccine. The  patient came into the pharmacy on 12/5/17 at approximately 9:50am reporting arm pain.
Myalgia, Arthralgia, Fever, Diarrhea,  NauseaVomiting, chills/ fatigue Narrative:
itchy all over; They have been getting worse in the past two hours; This is a spontaneous report received from a contactable consumer (patient) reported for herself. A 40-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6206, Expiration date: unknown) via an unspecified route of administration, administered in right arm on an unspecified date (age at vaccination was unknown) as dose 1, single for COVID-19 immunization. The patient did not have any medical history. The patient's concomitant medications were not reported. The patient was calling because she had the Pfizer vaccine that day (reported as yesterday) and she did not have a rash but she was itchy all over on an unspecified date. The patient had no rash, but it was getting more itchy. The patient started experiencing the problem that day (reported as today). The patient was still experiencing the problem. The patient stated that the events had been getting worse in the past two hours on an unspecified date. The patient did not take any treatment for the events and had not done anything. The outcome of the events was not resolved.  No follow-up attempts are needed. No further information is expected.
Site: Pain at Injection Site-Mild, Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Severe, Systemic: Hypotension-Medium, Additional Details: Fainted, lost consciousness and fell to floor. Hit head and had redness above eye brow. Patient said he had anxiety surrounding needles. Wife will bring to ER
Initial presentation was chest pain for 3 days. I was seen by a cardiologist. Diagnosis: Unstable Angina I was given a loading dose of Heparin, Aspirin, Concor and Crestor. Chest pain persisted and I was admitted to hospital on May 7, 2021, treated and sent home on May 9, 2021. Intermittent bouts of chest pain over the last 2 weeks. I returned to the cardiologist on May 19, 2021. Diagnosis: Pericarditis. I am currently being treated with Arcoxia.
LEFT ARM PAIN, LIMITED RANGE OF MOTION, "BLACKISH" FLUIDS FROM SITE DUE TO  DRAINING VACCINE SITE
On 09/09/2021 I lost my sense of smell and taste, I had congestion, temperature for a few days, the highest was about 99.7. On 09/12/2021 I went to urgent care and got tested for COVID-19, which came back positive. They did not give me any medications they just told me to take normal cold medicine. Towards the end I was really fatigued.
No adverse event; 47 patients received the Moderna Covid-19 bivalent vaccine after the use-by date.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (47 patients received the Moderna Covid-19 bivalent vaccine after the use-by date.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7642B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 28-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 28-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (47 patients received the Moderna Covid-19 bivalent vaccine after the use-by date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (47 patients received the Moderna Covid-19 bivalent vaccine after the use-by date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (47 patients received the Moderna Covid-19 bivalent vaccine after the use-by date.).    Patient was over 18 years of age. No relevant concomitant medications were reported. Staff gave patients vaccines past the use date of 18 Jun 2023. On 28 Jun 2023, 9 doses were administered at administration site 1. No treatment medication reported.   This case was for the 9th patient out of 47 reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-732752 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2023: Live Follow-up received contains Vaccine information reported and narrative updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-732752:Master Case (Patient 1)
Pt received vaccine and was cleared for discharge after 15 minute evaluation. Pt left clinic site and saw a friend and sat down to speak to this person for a few minutes. During this interaction, the pt began to feel unwell and apparently fainted. The nurse gave oxygen and alerted EMS. Vital signs were assessed and were stable; the pt regained alertness rapidly prior to her disposition by ambulance for emergency evaluation.
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 76-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination. No Medical History information was reported. On 11-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 11-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No Concomitant No Treatment medications were reported.
Patient had swelling, redness at injection site, itching of left arm only.  Swelling of arm can be attributed to previous removal of lymph nodes in same arm.  Patient forgot to tell Pharmacist prior to time of injection.  As of 9/18/13, patient has no redness or itching and swelling was minimal.  Patient refused seeing MD to confirm diagnosis.  No fever was noted by patient at any time.